Skip to Main Content

Paper Details

A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates.
Nat Commun
25
2023
COVID-19, CoV, DCFHP, SARS, SARS-CoV-2, alum, aluminum hydroxide, cell line, ferritin, human, infants
Author NameAffiliation
Prabhu S ArunachalamInstitute for Immunity, Stanford University School of Medicine
Jane FontenotNew Iberia Research Center, University of Louisiana at Lafayette
Francois VillingerNew Iberia Research Center, University of Louisiana at Lafayette
Bali PulendranInstitute for Immunity, Stanford University School of Medicine
Bali PulendranStanford University School of Medicine
Bali PulendranStanford University School of Medicine
Bali PulendranInstitute for Immunity, Stanford University School of Medicine
Bali PulendranStanford University School of Medicine
Bali PulendranStanford University School of Medicine
  • 1 - 9

Datasets

Release 1.2